Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rectal Disclofenac Versus Indomethacin for Prevention of Post-ERCP Pancreatitis (DIPPP): A Multicentre, Double-blind, Randomised, Controlled Trial

NCT05947461 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT05947461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05947461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rectal Disclofenac Versus Indomethacin for Prevention of Post-ERCP Pancreatitis (DIPPP): A Multicentre, Double-blind, Randomised, Controlled Trial
Lead sponsor
Air Force Military Medical University, China
Phase
Not applicable
Overall status
Terminated
Start date
June 1, 2023
Completion date
June 22, 2024
Enrollment
1,204 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

diclofenac, endoscopic retrograde cholangiopancreatography, indomethacin, nsaids, post-ercp acute pancreatitis